Albert J Czaja Selected Research

Autoimmune Hepatitis

11/2022	Advancing Biologic Therapy for Refractory Autoimmune Hepatitis.
1/2022	Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis.
1/2022	Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
10/2021	Review article: targeting the B cell activation system in autoimmune hepatitis.
1/2021	Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.
1/2020	Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.
1/2019	Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
1/2019	Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
1/2019	Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis.
1/2019	Editorial: the role of vitamin D in autoimmune hepatitis-authors' reply.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert J Czaja Research Topics

Disease

92	Autoimmune Hepatitis 11/2022 - 02/2002
27	Fibrosis (Cirrhosis) 01/2019 - 11/2002
17	Liver Diseases (Liver Disease) 01/2022 - 10/2003
10	Hepatitis 01/2019 - 07/2008
8	Necrosis 03/2016 - 05/2003
6	Disease Progression 01/2019 - 05/2002
6	Liver Failure 01/2019 - 05/2004
6	Chronic Hepatitis (Chronic Active Hepatitis) 03/2012 - 12/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2018
5	Inflammation (Inflammations) 01/2022 - 10/2007
5	Infections 01/2019 - 05/2002
5	End Stage Liver Disease 12/2018 - 10/2007
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017 - 02/2002
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 07/2013 - 01/2005
4	Vitamin D Deficiency 01/2019 - 04/2018
4	Immune System Diseases (Immune Disorders) 01/2017 - 09/2002
4	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2016 - 07/2010
4	Celiac Disease (Celiac Sprue) 12/2007 - 05/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 06/2009
3	Sclerosing Cholangitis 07/2013 - 02/2008
2	Pathologic Constriction (Stenosis) 01/2017 - 09/2014
2	Drug-Related Side Effects and Adverse Reactions 08/2014 - 08/2002
2	Virus Diseases (Viral Diseases) 04/2013 - 01/2011
2	Rheumatoid Arthritis 10/2012 - 06/2006
2	Thiopurine S methyltranferase deficiency 05/2007 - 05/2006
2	Cholangitis 05/2003 - 12/2002
1	Hemochromatosis (Bronze Diabetes) 01/2019
1	Hyperferritinemia 01/2019
1	Iron Overload 01/2019
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Alcoholic Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

31	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016 - 04/2002
24	AntibodiesIBA 01/2019 - 02/2002
19	AutoantibodiesIBA 12/2018 - 11/2002
14	Pharmaceutical PreparationsIBA 08/2014 - 04/2002
9	Azathioprine (Imuran)FDA LinkGeneric 08/2014 - 08/2002
8	AntigensIBA 01/2017 - 01/2005
8	liver antigen LA-1IBA 01/2012 - 02/2002
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 10/2005
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2010
6	Prednisone (Sone)FDA LinkGeneric 09/2012 - 08/2002
5	CytokinesIBA 01/2022 - 12/2002
5	Immunoglobulin G (IgG)IBA 12/2018 - 07/2008
5	ChromatinIBA 04/2018 - 08/2003
5	Sirolimus (Rapamycin)FDA Link 10/2012 - 05/2006
4	Biological ProductsIBA 11/2022 - 01/2021
4	EnzymesIBA 04/2018 - 05/2006
4	AutoantigensIBA 10/2015 - 05/2002
4	Immunoglobulins (Immunoglobulin)IBA 02/2013 - 07/2008
4	Immunosuppressive Agents (Immunosuppressants)IBA 09/2012 - 12/2002
4	Antinuclear AntibodiesIBA 02/2011 - 09/2002
4	HLA-DRB1 Chains (HLA DRB1)IBA 02/2008 - 12/2006
3	B-Cell Activating FactorIBA 11/2022 - 06/2018
3	Monoclonal AntibodiesIBA 11/2022 - 09/2012
3	LigandsIBA 10/2021 - 06/2018
3	Vitamin D FDA LinkGeneric 01/2019 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2016
3	Transaminases (Aminotransferases)IBA 12/2018 - 05/2006
3	Transcription Factors (Transcription Factor)IBA 04/2018 - 06/2013
3	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2005
3	SteroidsIBA 07/2013 - 09/2012
3	Asialoglycoprotein ReceptorIBA 08/2010 - 01/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 06/2006 - 08/2002
2	Interleukin-2 (IL2)IBA 11/2022 - 01/2021
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 11/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2018
2	GlucocorticoidsIBA 01/2020 - 01/2019
2	Histones (Histone)IBA 04/2018 - 01/2005
2	Alkaline PhosphataseIBA 01/2017 - 07/2013
2	AntioxidantsIBA 11/2016 - 10/2016
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2015 - 10/2010
2	Calcineurin InhibitorsIBA 02/2015 - 01/2007
2	Protein Glutamine gamma Glutamyltransferase 2IBA 05/2013 - 04/2004
2	Immunoglobulin A (IgA)IBA 05/2013 - 12/2010
2	Thioguanine (Tioguanine)FDA Link 10/2012 - 01/2007
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2012 - 05/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2012 - 05/2002
2	GlobulinsIBA 03/2012 - 05/2011
2	RibonucleoproteinsIBA 01/2012 - 04/2005
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 12/2010 - 01/2005
2	cyclic citrullinated peptideIBA 08/2010 - 06/2006
2	Peptides (Polypeptides)IBA 06/2006 - 10/2002
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2005 - 10/2003
1	Rituximab (Mabthera)FDA Link 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	Infliximab (Remicade)FDA Link 11/2022
1	belimumabIBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	InterferonsIBA 01/2021
1	2-mercaptopurineIBA 01/2020
1	Ferritins (Ferritin)IBA 01/2019
1	IronIBA 01/2019

Therapy/Procedure

44	Therapeutics 01/2022 - 04/2002
24	Liver Transplantation 01/2019 - 06/2002
6	Transplantation 01/2019 - 06/2002
3	Drug Therapy (Chemotherapy) 08/2014 - 10/2012
1	Biological Therapy 11/2022
1	Injections 01/2021